An experimental once-weekly insulin known as efsitora has shown comparable effectiveness to daily insulin regimens in ...

A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction ...

While severe maternal hypothyroidism (low thyroid hormone levels) in pregnancy is known to increase risks of adverse ...

This discovery could make treatment for an eye disease affecting millions with diabetes more accessible and affordable.

Discover how a 5-day fasting-mimicking diet revolutionizes type 2 diabetes management, reducing medications and improving ...

The addition of anagliptin to insulin and metformin therapy may improve glycemic control in patients with type 2 diabetes while maintaining an acceptable safety profile.

Metformin use may enhance progression-free survival (PFS) in patients receiving first-line systemic therapy for patients with ...

Treating cancer patients who have type II diabetes is a challenge, especially as cardiac, renal, and neurologic complications need to be considered. This review discusses the evidence from ...

Syntis Bio, Inc. (Syntis), a clinical-stage biopharmaceutical company revolutionizing oral therapies for obesity, diabetes ...

In a system often short on resources, it is these moments of human intuition and perseverance that define the best of Indian ...

Another major insurance change coming next year will affect another large swath of Dushay’s patients: In January, BCBS ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.